Mayank Bansal, CFA
Mayank Bansal is a CFA Charterholder and heads the Equity Research team at Kapitales Research, with over 5 years of experience analysing global equity markets. He leads fundamental, data-driven research combining rigorous financial analysis with macro trends.
Pro Medicus Secures AU$43 million Contract with Virtua Health for Cloud-Based Imaging Platform
Highlights
Pro Medicus Limited (ASX: PME), a healthcare informatics company, announced on 21 October 2026 that its wholly owned US subsidiary, Visage Imaging, Inc., had secured a seven-year contract valued at AU$43 million with Virtua Health. Based in southern New Jersey, Virtua Health provides healthcare services through five hospitals and has approximately 15,000 colleagues and 3,000 affiliated doctors and clinicians.
The agreement strengthens Pro Medicus’ presence in the US healthcare technology market and expands the adoption of its cloud-based medical imaging solutions. The contract operates under a transaction-based licensing model, providing potential upside depending on platform usage. At the time of writing, Pro Medicus shares were trading at AU$193.17, up AU$8.34 or 4.51%.
Visage 7 Platform to Unify Enterprise Imaging
Under the agreement, Virtua Health will implement the cloud-based Visage 7 Enterprise Imaging Platform across its operations. The solution combines four products: Visage 7 Viewer, Visage 7 Workflow, Visage 7 Open Archive and Visage 7 Cardiology Imaging.
The platform is designed to bring medical imaging capabilities together within a unified system. As part of the deployment, Visage Imaging will migrate Virtua Health’s existing picture archiving and communication system (PACS) archives to Visage 7 Open Archive.
The arrangement will also enable enterprise-wide distribution of medical images through integration with Virtua Health’s electronic health record (EHR) system. This approach is intended to consolidate imaging functions and support access to medical images across the healthcare organisation.
Cloud Deployment and Implementation Timeline
Pro Medicus stated that planning for the implementation would commence immediately, using Visage Imaging’s established cloud-based deployment process. The system is targeted to go live in late Q2 or early Q3 of calendar year 2027.
The inclusion of cardiology imaging is a notable element of the agreement, extending the platform beyond core viewing, workflow and archiving functions. Pro Medicus Chief Executive Officer Dr Sam Hupert said Virtua Health had selected the company’s fully cloud-based platform and cardiology offering to establish a unified enterprise imaging solution.
The company also highlighted continued demand for its broader integrated product suite, which combines its core imaging products with additional specialist applications.
Conclusion
The AU$43 million Virtua Health agreement represents a significant multi-year contract for Pro Medicus, supporting its expansion in the US healthcare technology sector. The cloud-based deployment and transaction-linked licensing structure provide an opportunity to strengthen the company’s enterprise imaging business, with implementation expected to progress through 2027.
Note: All data presented is based on information available at the time of writing.
Disclaimer for Kapitales Research The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.